Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Juan V Mulet Bayona"'
Autor:
Juan V. Mulet Bayona, Nuria Tormo Palop, Carme Salvador García, Paz Herrero Rodríguez, Vicente Abril López de Medrano, Carolina Ferrer Gómez, Concepción Gimeno Cardona
Publikováno v:
Antibiotics, Vol 9, Iss 9, p 558 (2020)
The multi-resistant yeast Candida auris has become a global public health threat because of its ease to persist and spread in clinical environments, especially in intensive care units. One of the most severe manifestations of invasive candidiasis is
Externí odkaz:
https://doaj.org/article/1215824b650e4caa9b9d6b7f69cc4921
Autor:
Juan V Mulet Bayona, Manuel Belda Álvarez, Mercedes García, Nuria Tormo Palop, María del Remedio Guna Serrano, Carme Salvador García, Concepción Gimeno Cardona, David Navalpotro Rodríguez
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 38:39-44
Resumen Candida auris es una levadura multirresistente emergente que causa infecciones invasivas graves y brotes con una alta mortalidad. El control de C . auris es un reto. Laboratorios, clinicos e instituciones sanitarias deben trabajar conjuntamen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::255c370f8e6dc69f76124889a5abcf5d
https://doi.org/10.1016/j.eimc.2020.02.007
https://doi.org/10.1016/j.eimc.2020.02.007
Autor:
Juan V Mulet Bayona, Begoña Fuster Escrivá, Mercedes Chanzá Aviñó, Concepción Gimeno Cardona, Carme Salvador García, Nuria Tormo Palop, Pilar Ortega García
Publikováno v:
Journal of Fungi
Journal of Fungi, Vol 7, Iss 440, p 440 (2021)
Volume 7
Issue 6
Journal of Fungi, Vol 7, Iss 440, p 440 (2021)
Volume 7
Issue 6
In addition to the increase in fungal infections that has been observed in the last few decades, it has been reported that severe clinical COVID-19 can increase the risk of invasive fungal infections. The main objective of this study was to evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2229e4148f776919e1b0d1f0cf2e282c
http://europepmc.org/articles/PMC8228091
http://europepmc.org/articles/PMC8228091
Publikováno v:
MycosesREFERENCES. 64(6)
Background Rapid and reliable laboratory methods are required for detecting the nosocomial yeast Candida auris. AurisID® (Olm Diagnostics, England) is a real-time PCR assay approved for detecting C. auris in fungal cultures as well as directly from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d34874a97403ca5c5ee94bdd70d8a5de
https://pubmed.ncbi.nlm.nih.gov/33529398
https://pubmed.ncbi.nlm.nih.gov/33529398
Publikováno v:
Diagnostic microbiology and infectious disease. 98(4)
A shift to Candida non-albicans infections has been noted during the last years, and the emergence of multi-resistant Candida auris has complicated their management. The aim of this study was first to compare the performance of the novel chromogenic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0c079db93d711224703a4514741e404
https://pubmed.ncbi.nlm.nih.gov/32927410
https://pubmed.ncbi.nlm.nih.gov/32927410